Effect of four oral contraceptives on hemostatic parameters

This publication has 55 references indexed in Scilit:

• Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
  Blood, 2003
• Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study
  The Lancet, 1999
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives
  BJOG: An International Journal of Obstetrics and Gynaecology, 1996
• A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol
  Contraception, 1996
• Ethinylestradiol 20 versus 30 μg combined with 150 μg desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system
  Gynecological Endocrinology, 1996
• The risk of venous thromboembolism associated with low oestrogen oral contraceptives
  Journal of Obstetrics and Gynaecology, 1995
• Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
  BMJ, 1993
• Steroidal contraceptives and changes in individual plasma phospholipids: possible role in thrombosis
  Advances in Contraception, 1990
• A comparison of the effects of two triphasic oral contraceptives on haemostasis
  British Journal of Haematology, 1988